as on November 26, 2025 at 2:29 am IST
Day's Low
Day's High
7.48%
Downside
0.49%
Upside
52 Week's Low
52 Week's High
21.94%
Downside
119.20%
Upside
Check Agios Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.5B
EPS (TTM)
-7.0063
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
1.63
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-470.3M
Revenue (TTM)
44.8M
Profit Margin
0.00%
Return On Equity TTM
-27.57%
Track how Agios Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Agios Pharmaceuticals, Inc. in the last 5 years
Lowest (-8.34x)
December 31, 2020
Today (1.63x)
November 26, 2025
Industry (8.36x)
November 26, 2025
Highest (2.47x)
June 30, 2021
Today’s Price to Earnings Ratio: 1.63x
Compare market cap, revenue, PE, and other key metrics of Agios Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.5B | -37.75% | 1.63 | 0.00% | |
| BUY | $44.6B | 441.78% | -16.34 | -264.83% | |
| BUY | $57.4B | 242.61% | 1447.43 | 1.36% | |
| BUY | $108.7B | 97.07% | 29.86 | 31.35% | |
| BUY | $80.7B | 54.89% | 18.25 | 32.13% |
The Agios Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Agios Pharmaceuticals, Inc. investment value today
Current value as on today
₹54,012
Returns
Returns from Agios Pharmaceuticals, Inc. Stock
Dollar Returns*
₹5,805 (+5.81%)
Based on 15 analysts
73.33%
Buy
26.67%
Hold
0.00%
Sell
Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Agios Pharmaceuticals, Inc.. Average target price of $31.29
Get share price movements and forecasts by analysts on Agios Pharmaceuticals, Inc..
What analysts predicted
8.95%UPSIDE
Target Price
$31.29
Current Price
$28.49
Analyzed by
15 Analysts
Target
$31.29
Agios Pharmaceuticals, Inc. target price $31.29, a slight upside of 8.95% compared to current price of $28.49. According to 15 analysts rating.
Investment in Agios Pharmaceuticals, Inc. Shares on INDmoney has grown by 1639.99% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1639.99% versus previous 30 day period
Search interest for Agios Pharmaceuticals, Inc. Stock has increased by 1785% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1785% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, AGIO stock has moved up by 18.6%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -112.02M → -103.43M (in $), with an average increase of 8.3% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 8.72M → 12.88M (in $), with an average increase of 16.6% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 173.4% return, outperforming this stock by 228.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1024.0% return, outperforming this stock by 1032.7%
| Organisation | Agios Pharmaceuticals, Inc. |
| Headquarters | 88 Sidney Street, Cambridge, MA, United States, 02139 |
| Industry | Health Technology |
| CEO | Mr. Brian M. Goff M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
Dr. Lewis clayton Cantley Ph.D. | Co-Founder |
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder |
Dr. Shin-San Su Ph.D. | Co-Founder |
Ms. Cecilia Jones | Chief Financial Officer |
Mr. James William Burns | Corporate Secretary & Chief Legal Officer |
Dr. Craig B. Thompson M.D. | Co-Founder |
Mr. T. J. Washburn | VP, Controller & Principal Accounting Officer |
Mr. Brian M. Goff M.B.A. | CEO & Director |
Ms. Tsveta Milanova | Chief Commercial Officer |
Agios Pharmaceuticals, Inc. share price today is $28.49 as on at the close of the market. Agios Pharmaceuticals, Inc. share today touched a day high of $28.63 and a low of $26.36.
Agios Pharmaceuticals, Inc. share touched a 52 week high of $62.45 on and a 52 week low of $22.24 on . Agios Pharmaceuticals, Inc. stock price today i.e. is closed at $28.49,which is 54.38% down from its 52 week high and 28.10% up from its 52 week low.
Agios Pharmaceuticals, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Agios Pharmaceuticals, Inc. (AGIO) shares with as little as ₹89.162 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹891.62 in Agios Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Agios Pharmaceuticals, Inc. share’s latest price of $28.49 as on November 26, 2025 at 2:29 am IST, you will get 0.3510 shares of Agios Pharmaceuticals, Inc.. Learn more about
fractional shares .
Agios Pharmaceuticals, Inc. stock has given -37.75% share price returns and 20.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?